| | Call Details | ev3 Inc. Earnings Conference Call (Q1 2008) Fri,
May 2, 2008, 8:30 am Eastern
| | About ev3 Inc.
(NasdaqGS:EVVV) |
| | ev3, Inc., a medical device company, focuses on catheter-based technologies for the endovascular treatment of vascular diseases and disorders. It develops, manufactures, and markets a range of products that include stents, atherectomy and thrombectomy products, balloon angioplasty catheters, microcatheters and occlusion balloon systems, embolic protection devices, infusion catheters/wires, embolic coils, and liquid embolics. The company markets its products in the United States, Europe, and Canada through a direct sales force, and through distributors in the United States and international markets. ev3, Inc. has a research collaboration with Merck & Co., Inc. for the analysis of atherosclerotic plaque removed from patient arteries with the goal of identifying new biomarkers of atherosclerotic disease progression and new therapies for atherosclerotic disease. The company is headquartered in Plymouth, Minnesota. |
| More
Info:
Quote
|
Profile
|
Reports
|
Research
|
Msgs
|
Insider
|
Financials
|
Analyst Ratings |
|